Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HCW Biologics Inc. | 5,720 | reported | 08 May 2025 | tx 16+215,786−17,142 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 May 2025 | PURCHASE | HCW Biologics Inc. | 962 | 26.00 USD | |
| 07 May 2025 | PURCHASE | HCW Biologics Inc. | 481 | 0.00 USD | derivfirst after silence |
| 20 Feb 2024 | GRANT_AWARD | HCW Biologics Inc. | 71,429 | 1.40 USD | |
| 08 Dec 2023 | EXERCISE | HCW Biologics Inc. | 7,501 | 0.14 USD | |
| 08 Dec 2023 | EXERCISE | HCW Biologics Inc. | 7,501 | 0.00 USD | deriv |
| 08 Jun 2023 | PURCHASE | HCW Biologics Inc. | 10,000 | 2.16 USD | first after silence |
| 08 Jun 2023 | EXERCISE | HCW Biologics Inc. | 5,356 | 0.14 USD | |
| 08 Jun 2023 | EXERCISE | HCW Biologics Inc. | 5,356 | 0.00 USD | deriv |
| 01 Dec 2021 | EXERCISE | HCW Biologics Inc. | 4,285 | 0.14 USD | |
| 01 Dec 2021 | EXERCISE | HCW Biologics Inc. | 4,285 | 0.00 USD | deriv |
| 08 Sept 2021 | GRANT_AWARD | HCW Biologics Inc. | 50,000 | 0.00 USD | deriv |
| 20 Aug 2021 | PURCHASE | HCW Biologics Inc. | 7,853 | 4.08 USD | |
| 23 Aug 2021 | PURCHASE | HCW Biologics Inc. | 5,605 | 3.95 USD | |
| 19 Aug 2021 | PURCHASE | HCW Biologics Inc. | 10,532 | 4.25 USD | |
| 22 Jul 2021 | PURCHASE | HCW Biologics Inc. | 31,250 | 8.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 07 May 2025.